Peptides/Nanomedicine for AS

Using biocompatible and biodegradable peptides in nanomedicine for atherosclerosis provides targeting and therapeutic functionality that can assist in overcoming delivery barriers of traditional drugs and makes them attractive for in vivo use. Here is the latest research.

January 16, 2022
Open Access

Endothelial Nitric Oxide Synthase (eNOS) S1176 phosphorylation status governs atherosclerotic lesion formation

BioRxiv : the Preprint Server for Biology
Monica Y LeeB. Sessa
January 16, 2022

Liraglutide prevents high glucose induced HUVECs dysfunction via inhibition of PINK1/Parkin-dependent mitophagy.

Molecular and Cellular Endocrinology
Yikai ZhangChao Zheng
January 15, 2022

Multiscale Simulation of Protein Corona Formation on Silver Nanoparticles: Study of Ovispirin-1 Peptide Adsorption.

The Journal of Physical Chemistry. B
Pranab SarkerTao Wei
January 15, 2022

NRP2 promotes atherosclerosis by upregulating PARP1 expression and enhancing low shear stress-induced endothelial cell apoptosis.

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
Shuai LuoJunjie Zhang
January 14, 2022

Endothelial Retargeting of AAV9 In Vivo.

Advanced Science
Tarik BozogluChristian Kupatt
January 14, 2022

The garlic-derived organosulfur compound diallyl trisulphide suppresses tissue factor function.

Food & Function
Sachiko OkueTaiichiro Seki
January 12, 2022

Bioactive components to inhibit foam cell formation in atherosclerosis.

Molecular Biology Reports
Sanjiv SinghV Ravichandiran
January 12, 2022

Self-Assembled Peptide Drug Delivery Systems.

ACS Applied Bio Materials
Jia YangHao Wang
January 12, 2022
Open Access

Stable flow-induced expression of KLK10 inhibits endothelial inflammation and atherosclerosis.

Darian WilliamsHanjoong Jo
January 10, 2022

Progerin-Expressing Endothelial Cells are Unable to Adapt to Shear Stress.

Biophysical Journal
Brooke E DanielssonDaniel E Conway
January 11, 2022

Design of the lentivirus-driven sustained LR12 delivery system for TREM-1 inhibition for palliating atherosclerosis.

Molecular and Cellular Biochemistry
Finosh G ThankamDevendra K Agrawal

Sign up to follow this feed and discover related papers.

Related Feeds

Artificial Cell Models

This feed focuses on biomimetrics, synthetic biology and bio- and tissue-engineering approaches used for modeling human diseases.

Artificial Heart & Ventricular Assist Devices

Total artificial hearts (TAH) and ventricular assist devices (VADs) provide cardiac support for patients with end-stage heart disease and have significantly improved the survival of these patients. Discover the latest research on Artificial Heart and Ventricular Assist Devices here.

Biomaterial Engineering

Advances in biomaterial engineering have permitted the development of sophisticated drug-releasing materials with a biomimetic 3D support that allow a better control of the microenvironment of transplanted cells. Here is the latest research.

Brain Organoids in Disease Modeling

Brain organoids are three-dimensional cell culture models derived from human pluripotent stem cells. Since they resemble the embryonic brain, they can be used to help study brain biology, early brain development, and brain diseases. Discover the latest research on brain organoids in disease modeling here.

CFTR Mutant Structural Therapy

Over 1700 different mutations in the CFTR genes have been shown to cause cystic fibrosis. Here is the latest research on structural therapy for CFTR mutants.

CRISPR Genome Editing & Therapy

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of this system for gene editing and therapy in human diseases.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

CRISPR in Malaria

CRISPR-Cas system enables the editing of genes to create or correct mutations. This technology is being investigated to combat malaria by targeting specific stretches of vector DNA and editing the genome at precise locations. Here is the latest research.

Cancer Cell Invasion: Nanomedicine

Nanomedicine is a promising alternative for cancer detection and therapy that utilizes nanoparticles, such as liposomes. Nanoparticles can potentially target cancer cell invasion and metastasis. Discover the latest research on Cancer Cell Invasion: Nanomedicine here.

Cardiac Organoids

Cardiac organoids are 3D organ-like structures that can be derived from patients with cardiovascular diseases and are important disease models for drug discovery. Discover the latest research on Cardiac Organoids here.

© 2022 Meta ULC. All rights reserved